Bionano Genomics Inc (BNGO)
0.7816
-0.03
(-4.19%)
USD |
NASDAQ |
Apr 18, 16:00
0.7985
+0.02
(+2.16%)
After-Hours: 20:00
Bionano Genomics Total Assets (Quarterly): 214.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 214.40M |
| September 30, 2023 | 181.90M |
| June 30, 2023 | 271.38M |
| March 31, 2023 | 292.15M |
| December 31, 2022 | 307.50M |
| September 30, 2022 | 323.70M |
| June 30, 2022 | 321.55M |
| March 31, 2022 | 348.21M |
| December 31, 2021 | 377.10M |
| September 30, 2021 | 359.66M |
| June 30, 2021 | 356.81M |
| March 31, 2021 | 384.86M |
| December 31, 2020 | 60.45M |
| Date | Value |
|---|---|
| September 30, 2020 | 41.40M |
| June 30, 2020 | 27.20M |
| March 31, 2020 | 19.10M |
| December 31, 2019 | 30.21M |
| September 30, 2019 | 19.21M |
| June 30, 2019 | 25.21M |
| March 31, 2019 | 29.55M |
| December 31, 2018 | 24.80M |
| September 30, 2018 | 30.67M |
| June 30, 2018 | 18.09M |
| March 31, 2018 | 16.46M |
| December 31, 2017 | 10.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.10M
Minimum
Mar 2020
384.86M
Maximum
Mar 2021
208.53M
Average
271.38M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 4.250B |
| Azenta Inc | 2.824B |
| Harvard Bioscience Inc | 137.37M |
| Akoya Biosciences Inc | 180.37M |
| Singular Genomics Systems Inc | 265.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 118.25M |
| Shareholders Equity (Quarterly) | 96.16M |
| Debt to Equity Ratio | 0.7259 |
| Current Ratio | 1.401 |
| Net Debt Paydown Yield | -16.14% |